Gregory Knight - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Gregory Knight

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

JCO Oncology Practice|June 8, 2021

Levine Cancer Institute Financial Toxicity Tumor Board: A Potential Solution to an Emerging ProblemDerek Raghavan, Nicole A Keith, Hughes R Warden, et al.

Surgical Oncology|April 24, 2024

Surveillance evaluations in patients with stage I, II, III, or resectable IV melanoma who were treated with curative intent: A systematic reviewSudha Rajagopal, Xiaomei Yao, Wadid Abadir, et al.

Annals of Hematology|April 25, 2024

Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practiceAleksander Chojecki, Danielle Boselli, Allison Dortilus, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

JCO Oncology Practice|June 8, 2021

Levine Cancer Institute Financial Toxicity Tumor Board: A Potential Solution to an Emerging ProblemDerek Raghavan, Nicole A Keith, Hughes R Warden, et al.

Surgical Oncology|April 24, 2024

Surveillance evaluations in patients with stage I, II, III, or resectable IV melanoma who were treated with curative intent: A systematic reviewSudha Rajagopal, Xiaomei Yao, Wadid Abadir, et al.

Annals of Hematology|April 25, 2024

Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practiceAleksander Chojecki, Danielle Boselli, Allison Dortilus, et al.

Pageof 2